stoxline Quote Chart Rank Option Currency Glossary
  
PepGen Inc. (PEPG)
17.48  -0.23 (-1.3%)    06-13 16:00
Open: 17.77
High: 17.98
Volume: 27,184
  
Pre. Close: 17.71
Low: 17.25
Market Cap: 567(M)
Technical analysis
2024-06-13 4:45:33 PM
Short term     
Mid term     
Targets 6-month :  21.46 1-year :  25.07
Resists First :  18.37 Second :  21.46
Pivot price 16.53
Supports First :  14.62 Second :  12.3
MAs MA(5) :  17.51 MA(20) :  15.81
MA(100) :  13.55 MA(250) :  9.2
MACD MACD :  1.1 Signal :  0.9
%K %D K(14,3) :  86.3 D(3) :  87
RSI RSI(14): 61.5
52-week High :  18.37 Low :  3.72
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PEPG ] has closed below upper band by 31.1%. Bollinger Bands are 8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 17.99 - 18.11 18.11 - 18.21
Low: 17.02 - 17.14 17.14 - 17.23
Close: 17.31 - 17.5 17.5 - 17.66
Company Description

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Headline News

Wed, 12 Jun 2024
PepGen (NASDAQ:PEPG) Hits New 52-Week High at $18.38 - MarketBeat

Tue, 11 Jun 2024
PepGen Announces Executive Team Promotions - Business Wire

Fri, 07 Jun 2024
PepGen (NASDAQ:PEPG) Shares Gap Down to $16.76 - Defense World

Mon, 03 Jun 2024
Head-To-Head Analysis: Sage Therapeutics (NASDAQ:SAGE) vs. PepGen (NASDAQ:PEPG) - Defense World

Sun, 26 May 2024
PEPG Stock Price and Chart — NASDAQ:PEPG — TradingView - TradingView

Wed, 22 May 2024
We're Not Very Worried About PepGen's (NASDAQ:PEPG) Cash Burn Rate - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 32 (M)
Shares Float 17 (M)
Held by Insiders 0 (%)
Held by Institutions 91 (%)
Shares Short 412 (K)
Shares Short P.Month 339 (K)
Stock Financials
EPS -3.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.53
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -26.6 %
Return on Equity (ttm) -46.8 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -2.63
Qtrly Earnings Growth 0 %
Operating Cash Flow -76 (M)
Levered Free Cash Flow -52 (M)
Stock Valuations
PE Ratio -5.4
PEG Ratio 0
Price to Book value 3.16
Price to Sales 0
Price to Cash Flow -7.45
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android